Pulmo Pharma was founded by graduates of the University of Technology Sydney (Australia), University of Rhode Island (USA), TU Munich (Germany), KU Leuven (Belgium), University of Tokyo (Japan), University of Tartu (Estonia), University of Oulu (Finland) and the University of Leicester (UK). We research pulmonary diseases & develop new therapies for patients suffering from hereditary and toxin caused lung diseases.